Cardiovascular disease mortality in patients with CKD is not only related to the severity of kidney disease but also to an increased systemic inflammatory burden; biomarkers such as C-reactive protein (CRP) and interleukin-6 (IL-6) are reliable predictors of cardiovascular and all-cause mortality in patients with CKD [6, 7]. This evidence concerns the gene IL6 and cardiovascular disorder.